|
Optimizing the Management of Endometrial Cancer |
0.50 |
07/01/2020 - 12:00am to 03/01/2021 - 12:00am |
|
New Therapeutic Developments in Urothelial Cancer: Clinical Trial Evidence and Expert Guidance |
1.75 |
07/02/2020 - 12:00am to 07/02/2021 - 12:00am |
|
Selection of Optimal First-Line and Maintenance Therapies in Advanced Ovarian Cancer |
1.00 |
07/08/2020 - 12:00am to 03/01/2021 - 12:00am |
|
Optimizing Treatment for Head and Neck Cancers |
1.50 |
07/09/2020 - 12:00am to 03/01/2021 - 12:00am |
|
NCCN Guidelines® Insights - Rectal Cancer, Version 6.2020 |
1.00 |
07/10/2020 - 12:00am to 07/10/2021 - 12:00am |
|
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Bladder Cancer |
1.00 |
07/10/2020 - 12:00am to 12/06/2020 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Breast Cancer |
0.75 |
07/13/2020 - 12:00am to 07/13/2021 - 12:00am |
|
BCOP Test - New Targets in Breast Cancer Therapy |
|
07/28/2020 - 2:00pm to 07/28/2021 - 12:00am |
|
Recorded Presentation from the NCCN Pharmacy Updates: New Targets in Breast Cancer Therapy |
1.00 |
08/04/2020 - 12:00am to 07/28/2021 - 12:00am |
|
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Prostate Cancer |
1.00 |
08/06/2020 - 12:00am to 08/06/2021 - 12:00am |
|
NCCN Guidelines® Insights - Survivorship, Version 2.2020 |
1.00 |
08/10/2020 - 12:00am to 08/10/2021 - 12:00am |
|
BCOP Test - Assessment and Management of CAR T-Cell Related Toxicities |
|
08/25/2020 - 3:00pm to 08/25/2021 - 12:00am |
|
BCOP Test - Novel Treatments for Neuroendocrine Tumors |
|
09/28/2020 - 4:00pm to 07/28/2021 - 12:00am |
|
BCOP Test - Establishing a Place in Therapy for Biosimilars in Oncology |
|
10/28/2020 - 1:30pm to 10/28/2021 - 12:00am |
|
BCOP Test - Treatment Advances for Pediatric B-Cell Non-Hodgkin's Lymphomas |
|
11/17/2020 - 5:00pm to 11/17/2021 - 12:00am |
Facebook
Twitter
LinkedIn
Forward